Research Papers

25 of 332 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Persons with rheumatoid arthritis have higher barriers to physical activity than controls: a cross-sectional study usin…
Videm V; Houge IS; Hoff M.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Radiological assessment and surgical management of cervical spine involvement in patients with rheumatoid arthritis.
Siempis T; Tsakiris C; Anastasia Z; Alexiou GA; Voulgaris S; Argyropoulou MI.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Digital health information on autoinflammatory diseases: a YouTube quality analysis.
Sasse M; Ohrndorf S; Palmowski A; Wagner AD; Burmester GR; Pankow A; Krusche M.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
`Risk of cardiovascular disease associated with febuxostat versus allopurinol use in patients with gout: a retrospectiv…
Jeong H; Choi E; Suh A; Yoo M; Kim B.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Effect of anti-inflammatory therapy on vascular biomarkers for subclinical cardiovascular disease in rheumatoid arthrit…
Blanken AB; Raadsen R; Agca R; van Sijl AM; Smulders YM; Nurmohamed MT.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Post-traumatic growth in adult patients with systemic lupus erythematosus: a cross-sectional study in China.
Xu R; Yan Q; Xu Z; Long X; Yin R.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Impact of COVID-19 pandemic on rheumatology trainees: an online survey.
Chandwar K; Mukherjee S; Ekbote D; Kishor K; Dogga P; Dixit J; Kumar P; Dhakad U.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Digitally supported shared decision-making and treat-to-target in rheumatology: a qualitative study embedded in a multi…
Muehlensiepen F; May S; Hadaschik K; Vuillerme N; Heinze M; Grahammer M; Labinsky H; Boeltz S; Detert J; Petersen J; Krönke G; Schett G; Knitza J.
Rheumatol Int (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Diagnostic delay stages and pre-diagnostic treatment in patients with suspected rheumatic diseases before special care …
Fuchs F; Morf H; Mohn J; Mühlensiepen F; Ignatyev Y; Bohr D; Araujo E; Bergmann C; Simon D; Kleyer A; Vorbrüggen W; Ramming A; Distler JHW; Bartz-Bazzanella P; Schett G; Welcker M; Hueber AJ; Knitza J.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Serum beta-2 microglobulin as a predictor of nephritis, disease activity, and damage score in systemic lupus erythemato…
Gamal DM; Badr FM; Taha SIAEF; Moustafa NM; Teama MAEM.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Impact of cigarette smoking on rheumatoid arthritis-associated lung diseases: a retrospective case control study on cli…
Ren J; Ding Y; Zhao J; Sun Y.
Rheumatol Int (Unknown)
Published: 2022
2/6 Transparent
Management of chronic rheumatic diseases in women 18-45 years of age in Asia Pacific: insights from patient and clinici…
Tanaka Y; Barrett C; Hirano Y; Ikeda K; Paizis K; Sameshima A; Mountian I; Wong PC.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Efficacy and safety of a mobile app intervention in patients with inflammatory arthritis: a prospective pilot study.
Fedkov D; Berghofen A; Weiss C; Peine C; Lang F; Knitza J; Kuhn S; Krämer BK; Leipe J.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: a case series and literature review.
Sagy I; Zeller L; Raviv Y; Porges T; Bieber A; Abu-Shakra M.
Rheumatol Int (Unknown)
Published: 2022
2/6 Transparent
Comparison of physician and artificial intelligence-based symptom checker diagnostic accuracy.
Gräf M; Knitza J; Leipe J; Krusche M; Welcker M; Kuhn S; Mucke J; Hueber AJ; Hornig J; Klemm P; Kleinert S; Aries P; Vuillerme N; Simon D; Kleyer A; Schett G; Callhoff J.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Real-life data on tapering or discontinuation of canakinumab therapy in patients with familial Mediterranean fever.
Karabulut Y; Gezer HH; Öz N; Esen İ; Duruöz MT.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Microvascular capillaroscopic abnormalities and occurrence of antinuclear autoantibodies in patients with sarcoidosis.
Cattelan F; Hysa E; Gotelli E; Pizzorni C; Bica PF; Grosso M; Barisione E; Paolino S; Carmisciano L; Sulli A; Smith V; Cutolo M.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a syst…
Fatoye F; Gebrye T; Mbada C.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
COVAD survey 2 long-term outcomes: unmet need and protocol.
Fazal ZZ; Sen P; Joshi M; Ravichandran N; Lilleker JB; Agarwal V; Kardes S; Kim M; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Tan AL; Chatterjee T; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Selva-O'Callaghan A; Nune A; Nune A; Knitza J; Kuwana M; Gutiérrez CT; Caballero-Uribe CV; Dey D; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L; COVAD Study Group.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Urinary incontinence in systemic sclerosis: a prospective multicentre cohort study.
John G; Zanatta E; Polito P; Piantoni S; Fredi M; Coattrenec Y; Guemara R; Franceschini F; Truchetet ME; Cozzi F; Airò P; Chizzolini C.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Sarcoidosis with musculoskeletal manifestations: systematic review of non-pharmacological and pharmacological treatment…
Smedslund G; Kotar AM; Uhlig T.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The genetic backbone of ankylosing spondylitis: how knowledge of genetic susceptibility informs our understanding and m…
Kenyon M; Maguire S; Rueda Pujol A; O'Shea F; McManus R.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review.
Holzer MT; Krusche M; Ruffer N; Haberstock H; Stephan M; Huber TB; Kötter I.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Managing ANCA-associated vasculitis during COVID-19 pandemic: a single-center cross-sectional study.
Samanta J; Naidu G; Deo P; Mittal S; Prasad CB; Das D; Dhir V; Sharma SK; Ramachandran R; Rathi M; Nada R; Minz RW; Jain S; Sharma A.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Vasculitis flare after COVID-19: report of two cases in patients with preexistent controlled IgA vasculitis and review …
Valero C; Baldivieso-Achá JP; Uriarte M; Vicente-Rabaneda EF; Castañeda S; García-Vicuña R.
Rheumatol Int (Unknown)
Published: 2022
3/6 Transparent
Funding Declared